FDA Launches Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data in Food Animals

Dec 06, 2022

The U.S. Food and Drug Administration launched an Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data.

The display applies a biomass denominator to adjust existing annual antimicrobial sales and distribution data for medically important antimicrobial drugs sold or distributed for use in food-producing animals (cattle, swine, chickens, and turkeys) in the United States for years 2016 to 2020. Animal biomass is defined as the population of a given livestock species in the U.S. multiplied by the average weight of that species. In this method, a biomass denominator adjusts annual antimicrobial sales data to account for the size of the population of a given livestock species in the U.S. potentially being treated with those drugs.

See the interactive summary at https://www.fda.gov/animal-veterinary/antimicrobial-resistance/biomass-adjusted-antimicrobial-sales-and-distribution-data-food-producing-animals-interactive.

The interactive summary allows users to customize data visualizations using criteria such as antimicrobial drug class, species, and year.

Click here to see more...

Video: Decoding Pig Performance With AI And Transcriptomics - Dr. Maria Walsh

The Swine it Podcast Show, Dr. Maria Walsh, Chief Operating Officer at Biofractal, explains how transcriptomics and AI are helping swine producers better understand the gap between genetic potential and commercial performance. Dr. Walsh discusses metabolic efficiency, disease resilience, PRRS challenges, and practical on-farm biological insights using blood samples and AI-powered analysis. She also explains how nutrition, health, and production data can work together to improve decision-making. Listen now on all major platforms!

"Gene expression data provides biological insight into how pigs respond to nutrition, stress, and health challenges before visible production losses occur."